Lista de obras - Christopher B Fox - Dominio Público Uruguay

3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates

scientific article published on 01 June 2020

A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93.

scientific article published on 03 January 2014

A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2--a GLURP-MSP3 fusion protein malaria vaccine candidate

artículo científico publicado en 2011

AS03 stresses out macrophages: Commentary on ‘Activation of the endoplasmic reticulum stress sensor IRE1α by the vaccine adjuvant AS03 contributes to its immunostimulatory properties’.

artículo científico publicado en 2018

Adjuvant composition and delivery route shape immune response quality and protective efficacy of a recombinant vaccine for Entamoeba histolytica.

artículo científico publicado en 2018

Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis

artículo científico publicado en 2013

Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy

artículo científico publicado en 2012

Adjuvants for Leishmania vaccines: from models to clinical application ⬇️

artículo científico publicado el 11 de junio de 2012

An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants.

artículo científico publicado en 2013

Characterization of TLR4 agonist effects on alhydrogel® sedimentation: a novel application of laser scattering optical profiling.

artículo científico publicado en 2012

Charged aerosol detection to characterize components of dispersed-phase formulations

artículo científico

Control of Heterologous Simian Immunodeficiency Virus SIV Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques

artículo científico publicado en 2018

Cryogenic transmission electron microscopy of recombinant tuberculosis vaccine antigen with anionic liposomes reveals formation of flattened liposomes

artículo científico publicado en 2014

Detecting phase transitions in phosphatidylcholine vesicles by Raman microscopy and self-modeling curve resolution

artículo científico publicado en 2007

Detection of drug-membrane interactions in individual phospholipid vesicles by confocal Raman microscopy

artículo científico publicado en 2006

Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant

artículo científico publicado en 2011

Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsions

artículo científico publicado en 2010

Effects on immunogenicity by formulations of emulsion-based adjuvants for malaria vaccines

artículo científico publicado en 2012

Elimination of the cold-chain dependence of a nanoemulsion adjuvanted vaccine against tuberculosis by lyophilization

scientific article published on 29 December 2013

Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice

artículo científico publicado en 2012

Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions.

artículo científico publicado en 2011

Immunomodulatory and physical effects of phospholipid composition in vaccine adjuvant emulsions.

artículo científico publicado en 2012

In vitro evaluation of TLR4 agonist activity: formulation effects

artículo científico publicado en 2013

Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsions

artículo científico publicado en 2010

Key roles of adjuvants in modern vaccines

artículo científico publicado en 2013

Microscopic rates of peptide-phospholipid bilayer interactions from single-molecule residence times.

artículo científico publicado en 2012

Modern Vaccines/Adjuvants Formulation Session 6: Vaccine &Adjuvant Formulation & Production 15-17 May 2013, Lausanne, Switzerland

artículo científico publicado en 2013

Modulating potency: Physicochemical characteristics are a determining factor of TLR4-agonist nanosuspension activity

artículo científico publicado en 2014

Monitoring the effects of component structure and source on formulation stability and adjuvant activity of oil-in-water emulsions

artículo científico publicado en 2008

Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activity

scientific article published on 21 December 2013

Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want

scientific article published on 10 October 2018

Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations

artículo científico publicado en 2009

Physicochemical structure of a polyacrylic acid stabilized nanoparticle alum (nanoalum) adjuvant governs TH1 differentiation of CD4+ T cells

scientific article published on 13 January 2020

Self-assembly of a triangle-shaped, hexaplatinum-incorporated, supramolecular amphiphile in solution and at interfaces

artículo científico publicado en 2009

Single-molecule fluorescence imaging of peptide binding to supported lipid bilayers

artículo científico publicado en 2009

Squalene Emulsion Manufacturing Process Scale-Up for Enhanced Global Pandemic Response

artículo científico publicado en 2020

Squalene emulsions for parenteral vaccine and drug delivery

artículo científico publicado en 2009

Synthetic and natural TLR4 agonists as safe and effective vaccine adjuvants

artículo científico publicado en 2010

TLR4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responses

artículo científico publicado en 2013

Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania ⬇️

artículo científico publicado el 25 de octubre de 2012

Temperature-controlled confocal Raman microscopy to detect phase transitions in phospholipid vesicles

artículo científico publicado en 2007

Use of defined TLR ligands as adjuvants within human vaccines.

artículo científico publicado en 2011

Lista de obras de Christopher B Fox

3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates

A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93.

A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2--a GLURP-MSP3 fusion protein malaria vaccine candidate

AS03 stresses out macrophages: Commentary on ‘Activation of the endoplasmic reticulum stress sensor IRE1α by the vaccine adjuvant AS03 contributes to its immunostimulatory properties’.

Adjuvant composition and delivery route shape immune response quality and protective efficacy of a recombinant vaccine for Entamoeba histolytica.

Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis

Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy

Adjuvants for Leishmania vaccines: from models to clinical application ⬇️

An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants.

Characterization of TLR4 agonist effects on alhydrogel® sedimentation: a novel application of laser scattering optical profiling.

Charged aerosol detection to characterize components of dispersed-phase formulations

Control of Heterologous Simian Immunodeficiency Virus SIV Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques

Cryogenic transmission electron microscopy of recombinant tuberculosis vaccine antigen with anionic liposomes reveals formation of flattened liposomes

Detecting phase transitions in phosphatidylcholine vesicles by Raman microscopy and self-modeling curve resolution

Detection of drug-membrane interactions in individual phospholipid vesicles by confocal Raman microscopy

Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant

Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsions

Effects on immunogenicity by formulations of emulsion-based adjuvants for malaria vaccines

Elimination of the cold-chain dependence of a nanoemulsion adjuvanted vaccine against tuberculosis by lyophilization

Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice

Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions.

Immunomodulatory and physical effects of phospholipid composition in vaccine adjuvant emulsions.

In vitro evaluation of TLR4 agonist activity: formulation effects

Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsions

Key roles of adjuvants in modern vaccines

Microscopic rates of peptide-phospholipid bilayer interactions from single-molecule residence times.

Modern Vaccines/Adjuvants Formulation Session 6: Vaccine &Adjuvant Formulation & Production 15-17 May 2013, Lausanne, Switzerland

Modulating potency: Physicochemical characteristics are a determining factor of TLR4-agonist nanosuspension activity

Monitoring the effects of component structure and source on formulation stability and adjuvant activity of oil-in-water emulsions

Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activity

Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want

Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations

Physicochemical structure of a polyacrylic acid stabilized nanoparticle alum (nanoalum) adjuvant governs TH1 differentiation of CD4+ T cells

Self-assembly of a triangle-shaped, hexaplatinum-incorporated, supramolecular amphiphile in solution and at interfaces

Single-molecule fluorescence imaging of peptide binding to supported lipid bilayers

Squalene Emulsion Manufacturing Process Scale-Up for Enhanced Global Pandemic Response

Squalene emulsions for parenteral vaccine and drug delivery

Synthetic and natural TLR4 agonists as safe and effective vaccine adjuvants

TLR4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responses

Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania ⬇️

Temperature-controlled confocal Raman microscopy to detect phase transitions in phospholipid vesicles

Use of defined TLR ligands as adjuvants within human vaccines.